Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.
Gut microbiota in early pediatric multiple sclerosis: a case-control study.
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
Case Report of Lewis and Sumner Syndrome with Bilateral Vagus Nerves Paralysis for 16 Years.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »